+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 14Years +
All Genders
Healthy Volunteers
ID05789901

Adapt and Evaluate MARVIN Chatbots Using Artificial Intelligence to Provide Health Information for HIV, Breast Cancer, Pediatric Infectious Conditions, and Pharmacists

Led by McGill University Health Centre/Research Institute of the McGill University Health Centre · Updated on 2024-03-06

400

Participants Needed

2

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a master research protocol to adapt and evaluate the MARVIN chatbot, an artificial intelligence-based conversational agent, for providing information across different health conditions such as HIV infections, breast cancer, and pediatric infectious conditions. This study uses an adaptive platform trial design to allow multiple chatbot interventions tailored to various populations, enabling early withdrawal of ineffective arms and introduction of new ones. The goal is to develop, adapt, and assess the usability and implementation outcomes of these chatbots through co-construction with participants and research teams. The study involves four chatbot interventions delivered via Meta Facebook Messenger MARVIN for HIV patients, MARVIN-Pharma for community pharmacists, MARVINA for breast cancer patients, and MARVIN-CHAMP for pediatric patients with infectious conditions. Participants will be involved in co-constructing the chatbots, usability studies, implementation, evaluation of outcomes, and continuous improvements. This ongoing process allows the chatbots to be progressively refined to meet the needs of each user group. Participants aged 14 and older who understand the study requirements and have access to a smartphone, tablet, or computer with internet or data plan will engage with the chatbots over time. Researchers will assess usability using tools like the Usability Metric for User eXperience UMUX-Lite and Acceptability E-Scale AES immediately and at intervals over 12 months. They will also evaluate implementation outcomes such as intervention appropriateness and compatibility. Throughout the study, participants interaction with the chatbots and their experience will be continuously monitored and improved.

CONDITIONS

Brief Title

The MARVIN Chatbots to Provide Information for Different Health Conditions

Research Team

B

Bertrand Lebouché, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here